With the excitement of RSNA already a distant memory, 2021 has well and truly kicked off. Blackford’s Platform Partners have started the year in typically busy fashion – here are the latest news updates from some of the companies in our ecosystem.
Medical imaging software firm Resonance Health was delighted to announce that its HepaFat-AI product has become the company’s second AI solution to receive FDA clearance. HepaFat-AI assesses the volumetric liver fat fraction, proton density fat fraction, and steatosis grade in individuals with confirmed or suspected fatty liver disease.
Musculoskeletal AI solutions developer Image Biopsy Lab revealed that it will present results of a reader study at the European Congress of Radiology 2021 in March. The study compares IB Lab PANDA software with a panel of three independent readers on a cohort of over 250 subjects for estimation of pediatric bone age.
Lung analysis firm VIDA unveiled a new look for the company’s brand, but also made several key announcements, including the release of new texture analysis and subpleural view features that are relevant for the analysis of interstitial abnormalities, including those commonly found in COVID-19.
VIDA also announced that UnityPoint Health has selected the company’s AI-powered lung intelligence for its 21-hospital network with VIDA’s AI-powered lung intelligence. The company also hosted an ILD-focused webinar where pulmonologists spoke candidly about what they really want from their radiologists when it comes to diffuse lung diseases. Furthermore, VIDA noted that AuntMinnie’s top story of RSNA 2020 was the work of two VIDA collaborators into wood smoke and lung damage.
Imaging AI specialist icometrix was in winning mood as it announced it had won awards, including in the health and wellbeing category at the UN World Summit Awards 2020 and the public award for best pitch at Brain Innovation Days. The company also spoke out on the need for personalized medicine in MS, and joined forces with the American Society of Functional Neuroradiology for its new webinar focused on perfusion methods.
In January, icometrix revealed that its icovid project is being rolled out for free in 800 hospitals in Europe and supported by research centres all over Europe. The pro bono initiative supports radiologists in the assessment of CT images of the lungs of COVID-19 patients.
Enhanced imaging AI firm Qure.ai published the results of its collaboration with the Neuroradiology team at Beth Israel Deaconess Medical Center of Harvard Medical School. The paper showed how the company’s head CT algorithm can be used to automate lateral ventricular and cranial vault volume measurements.
Qure also published a joint blog with vRad, a leading US teleradiology and telemedicine company, with more than 500+ radiologists serving over 2,000 facilities in the United States. The blog shared interesting insights on deploying AI solutions to handle workloads of this scale with high levels of accuracy and sensitivity.
Medical imaging enhancement specialist Subtle Medical revealed that Affidea, a leading pan-European provider of advanced diagnostic imaging, is aiming for lower FDG dose and a 50+% reduction in scan time with SubtlePET. The company was also mentioned in this Applied Radiology article by RadNet’s Dr. Larry Tanenbaum and Dr. Suzie Bash, which looks at deep learning’s potential to revolutionize image reconstruction.
And finally, AI-powered breast health solution provider Densitas published a new blog on how AI can support business continuity in breast screening, and highlighting some of the main challenges faced in mammography. The company also published an interesting blog highlighting some exciting new data generated by the recent analysis of the densitas intelliMammo platform by the Institute of Health Economics.
Stay tuned for more partner news next month!